Puma Biotech (NASDAQ: PBYI) reported Q4 EPS of $0.01, versus ($0.32) reported last year. Revenue for the quarter came in at $58.7 million versus the consensus estimate of $59.96 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.